BioAffinity Technologies Inc - Warrants(23/06/2027)
BIAFW
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.84M
Close$
$0.13
7.1% downside
Current Fair Value
7.1% downsideOvervalued by 7.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.84 Million |
|---|---|
| Enterprise Value | $2.15 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.66 |
| Beta | -1.34 |
| Outstanding Shares | 4,494,752 |
Return
| Return on Equity | -433.71% |
|---|---|
| Return on Assets | -199.87% |
| Return on Invested Capital | -242.70% |
Valuation & Multiples
| P/E Ratio | -0.07 |
|---|---|
| PEG | -0.18 |
| Price to Sales | 0.14 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.38 |
| Enterprise Value to EBIT | -0.19 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.66 |
| Debt to Equity | 0.39 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 20, 2026
EPS Estimate
$-2.40
Average shareholder expectationRevenue Estimate
$1.48 M
Average shareholder expectationNext Earnings Call
Expected Date
August 19, 2026
EPS Estimate
$-2.10
Average shareholder expectationRevenue Estimate
$1.70 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data